Circulating levels of TNF-α were found to be enhanced and negatively associated with the expression of the trophic factor IGF-1 in AD and MCI patients [60], and a recent investigation demonstrated that plasma and CSF analytes of the TNF signaling pathway correlate with CSF total tau in MCI patients [61]. Here, MAPT is linked to Alzheimer disease.